These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 22476980

  • 1. Natural inhibitors of poly(ADP-ribose) polymerase-1.
    Banasik M, Stedeford T, Strosznajder RP.
    Mol Neurobiol; 2012 Aug; 46(1):55-63. PubMed ID: 22476980
    [Abstract] [Full Text] [Related]

  • 2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 3. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L.
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [Abstract] [Full Text] [Related]

  • 4. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K, Besson VC, Szabó C.
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [Abstract] [Full Text] [Related]

  • 5. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L, Szabó C.
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [Abstract] [Full Text] [Related]

  • 6. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I, Cohen MS.
    Curr Protoc Chem Biol; 2015 Jun 01; 7(2):121-39. PubMed ID: 26344237
    [Abstract] [Full Text] [Related]

  • 7. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ, Szabó C.
    Curr Med Chem; 2003 Feb 01; 10(4):321-40. PubMed ID: 12570705
    [Abstract] [Full Text] [Related]

  • 8. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
    Meli E, Pangallo M, Baronti R, Chiarugi A, Cozzi A, Pellegrini-Giampietro DE, Moroni F.
    Toxicol Lett; 2003 Apr 04; 139(2-3):153-62. PubMed ID: 12628750
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.
    J Cereb Blood Flow Metab; 1997 Nov 04; 17(11):1143-51. PubMed ID: 9390645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
    Tiwari P, Khan H, Singh TG, Grewal AK.
    Neurochem Res; 2022 Jul 04; 47(7):1830-1852. PubMed ID: 35437712
    [Abstract] [Full Text] [Related]

  • 15. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 04; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 16. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD.
    Ann N Y Acad Sci; 2003 May 04; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [Abstract] [Full Text] [Related]

  • 17. Using Clickable NAD+ Analogs to Label Substrate Proteins of PARPs.
    Zhang L, Lin H.
    Methods Mol Biol; 2017 May 04; 1608():95-109. PubMed ID: 28695506
    [Abstract] [Full Text] [Related]

  • 18. Poly ADP-ribose polymerase-1 and health.
    Kirkland JB.
    Exp Biol Med (Maywood); 2010 May 04; 235(5):561-8. PubMed ID: 20463295
    [Abstract] [Full Text] [Related]

  • 19. Poly (ADP-ribose) polymerase, nitric oxide and cell death.
    Pieper AA, Verma A, Zhang J, Snyder SH.
    Trends Pharmacol Sci; 1999 Apr 04; 20(4):171-81. PubMed ID: 10322503
    [Abstract] [Full Text] [Related]

  • 20. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
    Chiarugi A, Moskowitz MA.
    J Neurochem; 2003 Apr 04; 85(2):306-17. PubMed ID: 12675907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.